Biologic agents used to treat rheumatoid arthritis and their relevance to podiatrists: a practice update

S J Otter; A Young; J R Cryer

doi:10.1002/msc.56

Biologic agents used to treat rheumatoid arthritis and their relevance to podiatrists: a practice update

Musculoskeletal Care. 2004;2(1):51-9. doi: 10.1002/msc.56.

Authors

S J Otter¹, A Young, J R Cryer

Affiliation

¹ School of Health Professions, University of Brighton. [email protected]

PMID: 17041968
DOI: 10.1002/msc.56

Abstract

This review considers the pharmacological management of rheumatoid arthritis including the role of anti-tumour necrosis factor alpha (TNFalpha) agents, as a precursor to highlighting some of the issues for podiatrists involved in the care of patients on this particular medication.